Company Encyclopedia
View More

Therapeutic Solutions International, Inc.
TSOI.US
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.
4.707 T
TSOI.USMarket value -Rank by Market Cap -/-
Valuation analysis

P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
- P/E
- Price
- High
- Median
- Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
- P/B
- Price
- High
- Median
- Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
- P/S
- Price
- High
- Median
- Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
- Dividend Yield
- Price
- High
- Median
- Low
Institutional View & Shareholder
Analyst Ratings
- Price--
- Highest--
- Lowest--
